In our research, we conducted a comprehensive analysis by collecting plasma samples from patients with lung adenocarcinoma (LUAD) and quantified the levels of Cellular Retinoic Acid Binding Protein 2 (CRABP2). The gene discussed is CRABP2; the disease is lung adenocarcinoma.